Danaher Corporation
DHR
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterizatioā¦ read more
Healthcare
Diagnostics & Research
47 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$208.36
Price-0.10%
-$0.20
1Y
Price
Market Cap
$147.290b
Large
Price/Earnings 3y Avg5y Avg
41.4x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+30.0%
EBITDA Margin+17.5%
Net Profit Margin+25.5%
Free Cash Flow Margin+30.0%
EBITDA Margin+17.5%
Net Profit Margin+25.5%
Free Cash Flow MarginRevenue
$24.568b
+2.9%
1y CAGR-2.5%
3y CAGR-4.3%
5y CAGREarnings
$3.614b
-7.3%
1y CAGR-19.8%
3y CAGR-11.8%
5y CAGREPS
$5.04
-4.7%
1y CAGR-18.5%
3y CAGR-10.9%
5y CAGRBook Value
$52.541b
$83.464b
Assets$30.930b
Liabilities$18.418b
DebtDebt to Assets
22.1%
2.6x
Debt to EBITDAFree Cash Flow
$5.260b
-0.7%
1y CAGR-10.2%
3y CAGR-6.6%
5y CAGRNo items found.
Press Releases
Statements and updates from the company